Transasia-Erba Groups’ international hematology range backed by European R&D, now in Pune

Priced 25% below comparable options, new range to make world-class diagnostics affordable for masses. End Quote

(1888PressRelease) May 08, 2019 - Transasia-Erba Group, India's No. 1 In-vitro Diagnostic (IVD) Company and among the leading global players focused on emerging markets, today as part of its 40th anniversary celebration announced that its international hematology range, is now available in Pune. Backed by European R&D, the 3-Part Differential Analyzer (3PDA) to 5-Part Differential Analyzer (5PDA) fully automated haematology analyzers, reagents and controls include a number of features to help institutions, clinicians and lab technologists offer accurate diagnosis. Manufactured by Erba Lachema (100% owned subsidiary of Transasia) in Europe, the H 360, H 560 and ELite 580 hematology analyzers are widely used in the European and global market. Hematology analyzers are extensively used in patient and research settings to count and characterize blood cells for disease detection and monitoring. Basic analyzers return a complete blood count (CBC) with a three-part differential white blood cell (WBC) count. Sophisticated analyzers measure cell morphology and can detect small cell populations to diagnose rare blood conditions.

In addition to the routine parameters, the new hematology range offers additional parameters such as Platelet Large Cell Ratio (PLCR) and Platelet Large Cell Concentration (PLCC) that are reported by advanced automated hematology analyzers to add more insight to the possible causes of abnormal platelet counts. The instruments thus become particularly relevant for Pune, since there is a huge influx of rural masses from the nearby areas. It has been observed that a majority of these patients suffer from anaemia, thalassemia, sickle cell anaemia, hemophilia and other hemoglobinopathies.

Addressing the media, Suresh Vazirani, Chairman and Managing Director, Transasia Bio-Medicals Ltd., said, “We are glad to be introducing our hematology range, here today. In Maharashtra, Pune holds the distinction of having a well developed healthcare infrastructure with a large number of specialized medical centres and hospitals. Infact, Pune is the only city in Maharashtra after Mumbai where Bone Marrow Transplant (BMT) is conducted. A BMT is critical for a large number of diseases of the blood. As a result, Pune attracts a lot of patients from the nearby areas for BMT. A hematology analyzer plays a very important role in the diagnosis of blood infections and also in the treatment options. Also, there is something very interesting about the healthcare industry in Pune. Pune is home to a lot of global medical professionals who prefer using the latest technology. On the other hand, the patient population in Pune are conservative when it comes to spending on healthcare. So Doctors prefer to use technology which can be offered to patients at an affordable rate. And that is where we will be able to meet the gap with this new range of hematology analyzers. These instruments have been developed at our European subsidiary and are designed to meet the needs for affordable diagnostics for the Indian markets.”

“The diagnostics industry in India suffers from an acute shortage of skilled manpower. Instead of talking about it, we as a responsible industry and market leader went ahead and invested in setting up India’s first such specialized training institute in Panchgani near Pune,” added Mr. Vazirani.

India ranks 145th among 176 countries on the quality and accessibility of healthcare parameter. Limited access to quality medical infrastructure, including skilled manpower and technologies have been the pain points of over 70% of Indians who live in smaller towns and rural areas. Transasia has been focusing on indigenous development & technology adoption which facilitates affordable diagnostics through domestic manufacturing.

Talking about the newly launched range, Dr. Preet Kaur, M.D. Pathology, Business Unit Head, Transasia said, “Accepted world-over for their quality, precision and ease-of-operation, the Erba range of hematology products will increase the adoption of automated hematology testing among Indian diagnostic labs. The range provides holistic solutions for clinical testing in general and targeted diagnostics which is an added advantage for pediatric and geriatric population. Other unique features include flagging of abnormal samples, RFID, large colored LCD touch screen, customizable reporting formats, ability to connect to a Laboratory Information System (LIS) for result output and ready-to-use reagents that are cyanide free and environment-friendly. By addressing many challenges that labs and pathologists face, Transasia is helping healthcare professionals (HCPs) focus on giving patients the best possible care.”

About Transasia Bio-Medicals Ltd.: Founded in 1979, Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company offers products and solutions in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics. Transasia provides doctors and patients with reliable, affordable and innovative Medical Diagnostic Systems, with an impressive install base of above 65,000 equipment across India. It has a vast network of the more than 250 service engineers, 400+ sales and marketing team, 23 zonal offices and 350+ distributors. It is the first Indian company to manufacture and export blood analyzers and reagents, in the 1990s. Today, Transasia’s indigenous research has resulted in development of state of the art, ‘Make in India’ products and technologies, enabling its products to be among the best in the world. All along its journey spanning more than four decades, Transasia has been recognized for its commitment to healthcare. It has been conferred ‘The Economic Times Best Brands 2019’ award, ‘India Medical Device - Export Company of the Year’ and the ‘Global Growth Company-2014’ award by the World Economic Forum amongst many others. Headquartered in Mumbai, Transasia is a part of the global Transasia-Erba group. The group has spread its footprint across USA, UK, Germany, Czech Republic, France, Italy, Russia and Turkey through various acquisitions. Transasia-Erba Group’s production sites in India, Czech Republic and USA and R&D centres in France, UK, India and Czech Republic form a hub for indigenous manufacturing of world class deliverables. Today, the group serves millions across 100 countries. For further information, kindly visit www.erbamannheim.com
For editorial queries only contact Sonam of PRHUB @ sonamm ( @ ) prhub dot com/9945017180.

###

space

Other Related Press Releases